Novartis Investigative Site

Dordrecht, South Holland 3318 AT

1 studies enrolling now · 3 studies all time

What they study most

Metastatic Hormone-sensitive Prostate Cancer, Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) — Running, not enrolling